Skip to content

Comparative Analysis Between Sleeve Gastrectomy and Roux-en Y Gastric Bypass in Bariatric Operation

Korean OBEsity Surgical Treatment Study(KOBESS-II) : Protocol of a Prospective Multicenter Cohort Study on Morbid Obesity Patients Undergoing Sleeve Gastrectomy Versus Roux-en Y Gastric Bypass

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04554758
Enrollment
400
Registered
2020-09-18
Start date
2020-09-01
Completion date
2023-08-31
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Weight Changes, Nutrition Disorders, Obesity, Morbid, Overnutrition, Overweight and Obesity

Keywords

primary bariatric surgery, morbid obesity, sleeve gastrectomy, Roux-en Y gastric bypass, South Korea

Brief summary

Prospective, double-arm, multi-center cohort study on obese patients, for laparoscopic sleeve gastrectomy versus Roux-en Y gastric bypass

Detailed description

This is prospective cohort study. Total 400 obese patients will be enrolled(Sleeve gastrectomy 200 patients, Roux-en-Y gastric bypass 200) The principal investigator or another clinical investigator in charge will individually inform the patients about the study, before operation at out patient clinic. At that time patient is selected to either sleeve gastrectomy group or Roux-en-Y gastric bypass group. All investigator report to clinical research center about patients BMI and operation method. About 30-35 obesity patients will be enrolled according to their BMI status. Patients' BMI status is classified into several parts by 2.5 gap started from 27.5. All patients will undergo periodically anthropometry, laboratory tests, bioelectrical impedance analysis, gastrofiberscopy, polysomnography and abdomen CT before and after surgery. Patients with hypertension will undergo echocardiography. Patients with polycystic ovary syndrome will be checked hormonal study. Patients with type 2 diabetes mellitus will be performed 75g oral glucose tolerance test test. Surgical complication include wound morbidities, gastrointestinal leakage or fistula, postoperative bleeding, intra-abdominal abscess, stricture , adhesive ileus, reflux esophagitis, marginal ulceration, dumping syndrome and internal hernia. Systemic complication which is not associated with the operation field include ling morbidities, heart morbidities, urinary morbidities and others. Hospital mortality is defined as postoperative death form any cause within 30 days after operation. All patients will be followed up post operative 1 month, 3 month, 6 month, 12 month, 18 month, 24 month. All patients' liver tissue, visceral fat and subcutaneous fat will be harvested during operation. All patients' blood sample will be collected at out patient clinic visit. All patients' urine and face will be collected at out patient clinic visit and will be analyzed to evaluate microbial change throughout pre and post operation period.

Interventions

PROCEDURESleeve gastrectomy

Bariatric operation will be done by laparoscopic sleeve gastrectomy procedure.

PROCEDURERoux-en-Y gastric bypass

Bariatric operation will be done by laparoscopic Roux-en-Y gastric bypass procedure.

Sponsors

Korean Center for Disease Control and Prevention
CollaboratorOTHER_GOV
Inha University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Comparative double arm study

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* obesity patients(BMI over 35) * morbid obesity patients(BMI over 30) with cardiovascular disease, hypertension, hyperlipidemia, type 2 diabetes mellitus, obstructive sleep apnea * type 2 diabetes mellitus obesity patients(BMI over 27.5) who were treated medical therapy or HbA1C level over 7%

Exclusion criteria

* Patients who underwent previously bariatric operation * Patients who were diagnosed malignant disease patients within 5 years * Patients who were involved with other clinical trial within 3 months * Patients who are risky to conduct general anesthesia for operation

Design outcomes

Primary

MeasureTime frameDescription
Obesity Cure Success RatePostoperative 1 yearProportion of patients who reach BMI bellow 25
Body weight change ratePostoperative 1 yearDecreased body weight proportion compare to preoperative body weight
Waist circumference change ratePostoperative 1 yearDecreased waist circumference change proportion compare to preoperative waist circumference

Secondary

MeasureTime frameDescription
Rate of morbid disease remission or partial remissionPostoperative 1 year, 2 yearRemission rate or partial remission rate of morbid disease related to obesity such as hypertension, type 2 diabetes mellitus, hyperlipidemia after surgery
Postoperative complication rate and mortality rateWithin postoperative 30 daysNumber of participants surgical complications associate with the surgical technique or the operation field Number of participants mortality after operation associated with surgical complication or underlying disease
Micronutrient deficiencyPostoperative 1 year, 2 yearIncidence of micronutrient deficiency rate such as vitamine, calcium, iron
Quality of life improvement rate and degree-1Postoperative 1 year, 2 yearPatients rate and quantitative analysis of the improved life quality using several survey EQ-5D-3L(EuroQol-5D) consists of 5 dimensions(mobility, self-care, usual activities, pain/discomfort and anxiety/depression). Each of which is scored as no/some/extreme problems. The dimension scores are converted into health utility scores ranging form 0(death) to 1(perfect health)
Quality of life improvement rate and degree-2Postoperative 1 year, 2 yearEQ-VAS(EuroQol-Visual Analogue scale) is a question scale ranging form 0 to 100. 0 indicated the worst and 100 indicated the best condition. EQ-VAS provides important, complementary information on patient's view about their own health.
Quality of life improvement rate and degree-3Postoperative 1 year, 2 yearImpact of Weight on QoL(IWQoL) has 5 dimensions and each dimension has several items. * physical function : 11 items * self-esteem : 7 items * sexual life : 4 items * public distress : 5 items * work : 4 items Score range from 0 to 100 and 100 represents the best quality of life.
Quality of life improvement rate and degree-4Postoperative 1 year, 2 yearMoore-head-Ardelt QoL questionnaire II(MA-II) has 6 items(general self-esteem, physical activity, social contacts, satisfaction concerning work, pleasure related to sexuality and focus on eating behavior). All items are scored according to 10-level Likert scale(-0.5 to 0.5) and all have the same weight.
Quality of life improvement rate and degree-5Postoperative 1 year, 2 yearObesity-related Psychosocial Problem scale(OP scale) consists of 8 items that measure the bothersome impact of body weight on given situations. (private gatherings in their own home, private gatherings at their friend or relative's home and going to restaurant)

Countries

South Korea

Contacts

Primary ContactYoon Seok Heo, Professor
gsheo@inha.ac.kr+82-32-890-3437
Backup ContactYun Suk Choi, Instructor
yunsukki@gmail.com+82-32-890-3437

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026